Resultados de la búsqueda 611-620 of 6336 for erectile dysfunction
The purpose of this study is to look at the effects cancer and melanoma have on the immune cells found in lymph nodes. Clinical Outcomes of Patients Treated ...
The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these cystic kidney ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Hensrud DD, ed. Add 5 habits. In: The Mayo Clinic Diet. 3rd ed. Mayo Clinic Press; 2023. Dietary supplements: What you need to know. Office of Dietary ...
Rochester, Minn. The purpose of this study is evaluate the outcomes and complications in patients who underwent a rotator cuff repair. Benevolent Tumor Tissue ...
Periorbital ecchymosis (black eye). In: Minor Emergencies. 4th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed April 8, 2024. Medical review ( ...
Actividad sexual frecuente: ¿protege contra el cáncer de próstata? Prostate Cancer Q and A. Mostrar más información relacionada. Hay un problema con la ...
Ectopic pregnancy: Etiology, pathology, diagnosis, management, fertility prognosis. In: Comprehensive Gynecology. 8th ed. Elsevier; 2022. https://www.
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...
paclitaxel and ramucirumab. Impact of Surgical Removal or Reduction Procedures on Markers of Immune Function in Adult Patients with Renal and Bladder Tumors and ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?